禁煙＆ニコチン依存症治療製品の世界市場2022-2031：産業分析、規模、シェア、成長、動向、予測

• 英文タイトル：Smoking Cessation and Nicotine De-Addiction Market [Product Type: Product with Nicotine (OTC Products, Prescription Products) and Product without Nicotine (Prescription Products)] Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022‒2031

• レポートコード：MRC2210A0036 • 出版社/出版日：Transparency Market Research / 2022年7月 • レポート形態：英文、PDF、375ページ • 納品方法：Eメール • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥857,660 (USD5,795)	▷ お問い合わせ
Multi User	￥1,301,660 (USD8,795)	▷ お問い合わせ
Corporate License	￥1,745,660 (USD11,795)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

Transparency Market Research社の本調査資料では、禁煙＆ニコチン依存症治療製品の世界市場を広く調査・分析し、序論、仮定、調査手法、エグゼクティブサマリー、市場概要、製品別（ニコチン入り製品（OTC製品、処方製品）、ニコチンなし製品（処方製品））分析、販売チャンネル別（オンライン、オフライン）分析、地域別（北米、ヨーロッパ、アジア太平洋、中東アフリカ、南米、その他）分析、競争状況など、以下の構成でまとめております。本書では、22nd Century Group, Inc.、Alkalon A/S、Cipla Ltd.、GlaxoSmithKline plc (GSK)、ITC Ltd.、Johnson & Johnson (J&J)、 JUUL Labs, Inc. 、Pfizer Inc.、 Strides Pharma Science Ltd.、Takeda Pharmaceutical Company Ltd.などの企業情報が含まれています。 ・序論 ・仮定 ・調査手法 ・エグゼクティブサマリー ・市場概要 ・世界の禁煙＆ニコチン依存症治療製品市場規模：製品別 - ニコチン入り禁煙＆ニコチン依存症治療製品の市場規模 - ニコチンなし禁煙＆ニコチン依存症治療製品の市場規模 ・世界の禁煙＆ニコチン依存症治療製品市場規模：販売チャンネル別 - オンライン販売チャンネルの市場規模 - オフライン販売チャンネルの市場規模 ・世界の禁煙＆ニコチン依存症治療製品市場規模：地域別 - 北米の禁煙＆ニコチン依存症治療製品市場規模 - ヨーロッパの禁煙＆ニコチン依存症治療製品市場規模 - アジア太平洋の禁煙＆ニコチン依存症治療製品市場規模 - 中東アフリカの禁煙＆ニコチン依存症治療製品市場規模 - 南米の禁煙＆ニコチン依存症治療製品市場規模 - その他地域の禁煙＆ニコチン依存症治療製品市場規模 ・競争状況

Smoking Cessation and Nicotine De-Addiction Market – Scope of Report
TMR’s report on the global smoking cessation and nicotine de-addiction market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2022 to 2031. The report provides revenue of the global smoking cessation and nicotine de-addiction market for the period 2017–2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global smoking cessation and nicotine de-addiction market from 2022 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the smoking cessation and nicotine de-addiction market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global smoking cessation and nicotine de-addiction market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the global smoking cessation and nicotine de-addiction market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global smoking cessation and nicotine de-addiction market.

The report delves into the competitive landscape of the global smoking cessation and nicotine de-addiction market. Key players operating in the global smoking cessation and nicotine de-addiction market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global smoking cessation and nicotine de-addiction market profiled in this report.

RESEARCH METHODOLOGY

The research methodology will be a combination of exhaustive primary and secondary research to analyze the market smoking cessation and nicotine de-addiction.

Secondary Research

Secondary research includes a search of company literature, technical writing, patent data, Internet sources, and statistical data from government websites, trade associations, and agencies. This has proven to be the most reliable, effective, and successful approach for obtaining precise data, capturing industry participants’ insights, and recognizing business opportunities.

Secondary research sources that we typically refer, but are not limited to:

Company websites, presentations, annual reports, white papers, technical paper, product brochure
Internal and external proprietary databases and relevant patents
National government documents, statistical databases, and market reports
News articles, press releases, and webcasts specific to companies operating in the market

Specific Secondary Sources:

Industry Sources:
WorldWideScience.org
Elsevier, Inc.
National Institutes of Health (NIH)
PubMed
NCBI
Department of Health Care Service
Trade Data Sources
Trade Map
UN Comtrade
Trade Atlas
Company Information
OneSource Business Browser
Hoover’s
Factiva
Bloomberg
Mergers & Acquisitions
Thomson Mergers & Acquisitions
MergerStat
Profound

Primary Research

During the course of research, we conduct in-depth interviews and discussions with a wide range of key industry participants and opinion leaders. Primary research represents bulk of research efforts, supplemented by extensive secondary research.

We conduct primary interviews on the ongoing basis with industry participants and commentators to validate data and analysis. A typical research interview fulfills the following functions:

Provides first-hand information on market size, market trends, growth trends, competitive landscape, outlook, etc.
Helps in validating and strengthening secondary research findings
Further develops the analysis team’s expertise and market understanding
Primary research involves e-mail interactions, telephonic interviews, as well as face-to-face interviews for each market, category, segment, and sub-segment across geographies

Participants who typically take part in such a process include, but are not limited to:

Industry participants: Marketing/product managers, market intelligence managers, and regional sales managers
Purchasing/Sourcing managers, technical personnel, distributors
Outside experts: Investment bankers, valuation experts, and research analysts specializing in specific markets
Key opinion leaders specializing in different areas corresponding to different industry verticals

List of primary participants, but not limited to:

Advanced Oncotherapy PLC
Danfysik A/S
Hitachi, Ltd.
IBA Worldwide
Mevion Medical Systems, Inc.

Data Triangulation: Information culled from “Secondary & Primary Sources” is cross-checked with “TMR Knowledge Repository”, which is updated every quarter.

Market Estimation: Market size estimations involved in-depth study of product features, technology updates, geographic presence, product demand, sales data (value or volume), historical year-on-year growth, and others. Other approaches were also utilized to derive market size and forecasts. Where no hard data was available, we employed modeling techniques in order to produce comprehensive datasets. A rigorous methodology has been adopted, wherein the available hard data are cross-referenced with the following data types to produce estimates:

Demographic Data: Healthcare expenditure, inflation rates, and others
Industry Indicators: R&D investment, technology stage, and infrastructure, sector growth, and facilities

Market Forecasting: Market forecasts for various segments are derived taking into account drivers, restraints/challenges, and opportunities prevailing in the market and considering advantages/disadvantages of segments/sub-segments over other segments/sub-segments. Business environment, historical sales pattern, unmet needs, competitive intensity, and country-wise surgery data are some of the other pivotal factors, which are considered to derive market forecasts.

レポート目次

---

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions
3. Research Methodology
4. Executive Summary
5. Market Overview
5.1. Market Dynamics
5.1.1. Drivers
5.1.2. Restraints
5.1.3. Opportunities
5.2. Key Trends Analysis
5.2.1. Demand Side Analysis
5.2.2. Supply Side Analysis
5.3. Key Market Indicators
5.4. Porter’s Five Forces Analysis
5.5. Value Chain Analysis
5.6. Industry SWOT Analysis
5.7. Global Smoking Cessation and Nicotine De-Addiction Market Analysis, 2017‒2031
5.7.1. Market Value Projections (US$ Mn)
6. Global Smoking Cessation and Nicotine De-Addiction Market Analysis and Forecast, by Product Type
6.1. Global Smoking Cessation and Nicotine De-Addiction Market Size (US$ Mn), by Product Type, 2017‒2031
6.1.1. Product (with nicotine)
6.1.1.1. OTC Products
6.1.1.1.1. E-cigarettes
6.1.1.1.2. Nicotine Gums (NRT)
6.1.1.1.3. Nicotine Patches (NRT)
6.1.1.1.4. Nicotine Lozenges (NRT)
6.1.1.1.5. Nicotine Tablets (NRT)
6.1.1.2. Prescription Products
6.1.1.2.1. Nicotine Sprays (NRT)
6.1.1.2.2. Nicotine Inhalers (NRT)
6.1.2. Product (without nicotine)
6.1.2.1. Prescription Products
6.1.2.1.1. Zyban
6.1.2.1.2. Chantix
6.2. Incremental Opportunity, by Product Type
7. Global Smoking Cessation and Nicotine De-Addiction Market Analysis and Forecast, by Distribution Channel
7.1. Global Smoking Cessation and Nicotine De-Addiction Market Size (US$ Mn)t, By Distribution Channel, 2017‒2031
7.1.1. Online
7.1.2. Offline
7.2. Incremental Opportunity, by Distribution Channel
8. Global Smoking Cessation and Nicotine De-Addiction Market Analysis and Forecast, Region
8.1. Global Smoking Cessation and Nicotine De-Addiction Market Size (US$ Mn), by Region, 2017‒2031
8.1.1. North America
8.1.2. Europe
8.1.3. Asia Pacific
8.1.4. Middle East & Africa
8.1.5. South America
8.2. Incremental Opportunity, by Region
9. North America Smoking Cessation and Nicotine De-Addiction Market Analysis and Forecast
9.1. Regional Snapshot
9.2. Price Trend Analysis
9.2.1. Weighted Average Selling Price (US$)
9.3. Key Trends Analysis
9.3.1. Demand Side Analysis
9.3.2. Supply Side Analysis
9.4. COVID-19 Impact Analysis
9.5. Key Supplier Analysis
9.6. Consumer Buying Behavior Analysis
9.7. Smoking Cessation and Nicotine De-Addiction Market Size (US$ Mn), by Product Type, 2017‒2031
9.7.1. Product (with nicotine)
9.7.1.1. OTC Products
9.7.1.1.1. E-cigarettes
9.7.1.1.2. Nicotine Gums (NRT)
9.7.1.1.3. Nicotine Patches (NRT)
9.7.1.1.4. Nicotine Lozenges (NRT)
9.7.1.1.5. Nicotine Tablets (NRT)
9.7.1.2. Prescription Products
9.7.1.2.1. Nicotine Sprays (NRT)
9.7.1.2.2. Nicotine Inhalers (NRT)
9.7.2. Product (without nicotine)
9.7.2.1. Prescription Products
9.7.2.1.1. Zyban
9.7.2.1.2. Chantix
9.8. Smoking Cessation and Nicotine De-Addiction Market Size (US$ Mn), by Distribution Channel, 2017‒2031
9.8.1. Online
9.8.2. Offline
9.9. Smoking Cessation and Nicotine De-Addiction Market Size (US$ Mn), by Country and Sub-region, 2017‒2031
9.9.1. U.S.
9.9.2. Canada
9.9.3. Rest of North America
9.10. Incremental Opportunity Analysis
10. Europe Smoking Cessation and Nicotine De-Addiction Market Analysis and Forecast
10.1. Regional Snapshot
10.2. Price Trend Analysis
10.2.1. Weighted Average Selling Price (US$)
10.3. Key Trends Analysis
10.3.1. Demand Side Analysis
10.3.2. Supply Side Analysis
10.4. COVID-19 Impact Analysis
10.5. Key Supplier Analysis
10.6. Consumer Buying Behavior Analysis
10.7. Smoking Cessation and Nicotine De-Addiction Market Size (US$ Mn), by Product Type, 2017‒2031
10.7.1. Product (with nicotine)
10.7.1.1. OTC Products
10.7.1.1.1. E-cigarettes
10.7.1.1.2. Nicotine Gums (NRT)
10.7.1.1.3. Nicotine Patches (NRT)
10.7.1.1.4. Nicotine Lozenges (NRT)
10.7.1.1.5. Nicotine Tablets (NRT)
10.7.1.2. Prescription Products
10.7.1.2.1. Nicotine Sprays (NRT)
10.7.1.2.2. Nicotine Inhalers (NRT)
10.7.2. Product (without nicotine)
10.7.2.1. Prescription Products
10.7.2.1.1. Zyban
10.7.2.1.2. Chantix
10.8. Smoking Cessation and Nicotine De-Addiction Market Size (US$ Mn) Forecast, by Distribution Channel, 2017‒2031
10.8.1. Online
10.8.2. Offline
10.9. Smoking Cessation and Nicotine De-Addiction Market Size (US$ Mn), by Country and Sub-region, 2017‒2031
10.9.1. U.K.
10.9.2. Germany
10.9.3. France
10.9.4. Rest of Europe
10.10. Incremental Opportunity Analysis
11. Asia Pacific Smoking Cessation and Nicotine De-Addiction Market Analysis and Forecast
11.1. Regional Snapshot
11.2. Price Trend Analysis
11.2.1. Weighted Average Selling Price (US$)
11.3. Key Trends Analysis
11.3.1. Demand Side Analysis
11.3.2. Supply Side Analysis
11.4. COVID-19 Impact Analysis
11.5. Key Supplier Analysis
11.6. Consumer Buying Behavior Analysis
11.7. Smoking Cessation and Nicotine De-Addiction Market Size (US$ Mn), by Product Type, 2017‒2031
11.7.1. Product (with nicotine)
11.7.1.1. OTC Products
11.7.1.1.1. E-cigarettes
11.7.1.1.2. Nicotine Gums (NRT)
11.7.1.1.3. Nicotine Patches (NRT)
11.7.1.1.4. Nicotine Lozenges (NRT)
11.7.1.1.5. Nicotine Tablets (NRT)
11.7.1.2. Prescription Products
11.7.1.2.1. Nicotine Sprays (NRT)
11.7.1.2.2. Nicotine Inhalers (NRT)
11.7.2. Product (without nicotine)
11.7.2.1. Prescription Products
11.7.2.1.1. Zyban
11.7.2.1.2. Chantix
11.8. Smoking Cessation and Nicotine De-Addiction Market Size (US$ Mn), by Distribution Channel, 2017‒2031
11.8.1. Online
11.8.2. Offline
11.9. Smoking Cessation and Nicotine De-Addiction Market Size (US$ Mn), by Country and Sub-region, 2017‒2031
11.9.1. China
11.9.2. India
11.9.3. Japan
11.9.4. Rest of Asia Pacific
11.10. Incremental Opportunity Analysis
12. Middle East & Africa Smoking Cessation and Nicotine De-Addiction Market Analysis and Forecast
12.1. Regional Snapshot
12.2. Price Trend Analysis
12.2.1. Weighted Average Selling Price (US$)
12.3. Key Trends Analysis
12.3.1. Demand Side Analysis
12.3.2. Supply Side Analysis
12.4. COVID-19 Impact Analysis
12.5. Key Supplier Analysis
12.6. Consumer Buying Behavior Analysis
12.7. Smoking Cessation and Nicotine De-Addiction Market Size (US$ Mn), by Product Type, 2017‒2031
12.7.1. Product (with nicotine)
12.7.1.1. OTC Products
12.7.1.1.1. E-cigarettes
12.7.1.1.2. Nicotine Gums (NRT)
12.7.1.1.3. Nicotine Patches (NRT)
12.7.1.1.4. Nicotine Lozenges (NRT)
12.7.1.1.5. Nicotine Tablets (NRT)
12.7.1.2. Prescription Products
12.7.1.2.1. Nicotine Sprays (NRT)
12.7.1.2.2. Nicotine Inhalers (NRT)
12.7.2. Product (without nicotine)
12.7.2.1. Prescription Products
12.7.2.1.1. Zyban
12.7.2.1.2. Chantix
12.8. Smoking Cessation and Nicotine De-Addiction Market Size (US$ Mn), by Distribution Channel, 2017‒2031
12.8.1. Online
12.8.2. Offline
12.9. Smoking Cessation and Nicotine De-Addiction Market Size (US$ Mn), by Country and Sub-region, 2017‒2031
12.9.1. GCC
12.9.2. South Africa
12.9.3. Rest of Middle East & Africa
12.10. Incremental Opportunity Analysis
13. South America Smoking Cessation and Nicotine De-Addiction Market Analysis and Forecast
13.1. Regional Snapshot
13.2. Price Trend Analysis
13.2.1. Weighted Average Selling Price (US$)
13.3. Key Trends Analysis
13.3.1. Demand Side Analysis
13.3.2. Supply Side Analysis
13.4. COVID-19 Impact Analysis
13.5. Key Supplier Analysis
13.6. Consumer Buying Behavior Analysis
13.7. Smoking Cessation and Nicotine De-Addiction Market Size (US$ Mn), by Product Type, 2017‒2031
13.7.1. Product (with nicotine)
13.7.1.1. OTC Products
13.7.1.1.1. E-cigarettes
13.7.1.1.2. Nicotine Gums (NRT)
13.7.1.1.3. Nicotine Patches (NRT)
13.7.1.1.4. Nicotine Lozenges (NRT)
13.7.1.1.5. Nicotine Tablets (NRT)
13.7.1.2. Prescription Products
13.7.1.2.1. Nicotine Sprays (NRT)
13.7.1.2.2. Nicotine Inhalers (NRT)
13.7.2. Product (without nicotine)
13.7.2.1. Prescription Products
13.7.2.1.1. Zyban
13.7.2.1.2. Chantix
13.8. Smoking Cessation and Nicotine De-Addiction Market Size (US$ Mn), by Distribution Channel, 2017‒2031
13.8.1. Online
13.8.2. Offline
13.9. Smoking Cessation and Nicotine De-Addiction Market Size (US$ Mn), by Country and Sub-region, 2017‒2031
13.9.1. Brazil
13.9.2. Rest of South America
13.10. Incremental Opportunity Analysis
14. Competition Landscape
14.1. Market Player – Competition Dashboard
14.2. Company Profiles (Details – Company Overview, Sales Area/Geographical Presence, Financial/Revenue, Strategy & Business Overview, Sales Channel Analysis, Size Portfolio)
14.2.1. Pfizer Inc.
14.2.1.1. Company Overview
14.2.1.2. Sales Area/Geographical Presence
14.2.1.3. Financial/Revenue
14.2.1.4. Strategy & Business Overview
14.2.1.5. Sales Channel Analysis
14.2.1.6. Size Portfolio
14.2.2. GlaxoSmithKline plc (GSK)
14.2.2.1. Company Overview
14.2.2.2. Sales Area/Geographical Presence
14.2.2.3. Financial/Revenue
14.2.2.4. Strategy & Business Overview
14.2.2.5. Sales Channel Analysis
14.2.2.6. Size Portfolio
14.2.3. Cipla Ltd.
14.2.3.1. Company Overview
14.2.3.2. Sales Area/Geographical Presence
14.2.3.3. Financial/Revenue
14.2.3.4. Strategy & Business Overview
14.2.3.5. Sales Channel Analysis
14.2.3.6. Size Portfolio
14.2.4. Johnson & Johnson (J&J)
14.2.4.1. Company Overview
14.2.4.2. Sales Area/Geographical Presence
14.2.4.3. Financial/Revenue
14.2.4.4. Strategy & Business Overview
14.2.4.5. Sales Channel Analysis
14.2.4.6. Size Portfolio
14.2.5. ITC Ltd.
14.2.5.1. Company Overview
14.2.5.2. Sales Area/Geographical Presence
14.2.5.3. Financial/Revenue
14.2.5.4. Strategy & Business Overview
14.2.5.5. Sales Channel Analysis
14.2.5.6. Size Portfolio
14.2.6. Takeda Pharmaceutical Company Ltd
14.2.6.1. Company Overview
14.2.6.2. Sales Area/Geographical Presence
14.2.6.3. Financial/Revenue
14.2.6.4. Strategy & Business Overview
14.2.6.5. Sales Channel Analysis
14.2.6.6. Size Portfolio
14.2.7. Alkalon A/S
14.2.7.1. Company Overview
14.2.7.2. Sales Area/Geographical Presence
14.2.7.3. Financial/Revenue
14.2.7.4. Strategy & Business Overview
14.2.7.5. Sales Channel Analysis
14.2.7.6. Size Portfolio
14.2.8. 22nd Century Group, Inc.
14.2.8.1. Company Overview
14.2.8.2. Sales Area/Geographical Presence
14.2.8.3. Financial/Revenue
14.2.8.4. Strategy & Business Overview
14.2.8.5. Sales Channel Analysis
14.2.8.6. Size Portfolio
14.2.9. Strides Pharma Science Ltd
14.2.9.1. Company Overview
14.2.9.2. Sales Area/Geographical Presence
14.2.9.3. Financial/Revenue
14.2.9.4. Strategy & Business Overview
14.2.9.5. Sales Channel Analysis
14.2.9.6. Size Portfolio
14.2.10. JUUL Labs, Inc.
14.2.10.1. Company Overview
14.2.10.2. Sales Area/Geographical Presence
14.2.10.3. Financial/Revenue
14.2.10.4. Strategy & Business Overview
14.2.10.5. Sales Channel Analysis
14.2.10.6. Size Portfolio
15. Key Takeaway

List of Tables

Table 1: Global Smoking Cessation and Nicotine De-Addiction Market Value, by product Type, US$ Mn, 2017‒2031

Table 2: Global Smoking Cessation and Nicotine De-Addiction Market Value, by Distribution Channel, US$ Mn,2017‒2031

Table 3: Global Smoking Cessation and Nicotine De-Addiction Market Value, by Region, US$ Mn, 2017‒2031

Table 4: North America Smoking Cessation and Nicotine De-Addiction Market Value, by product Type, US$ Mn, 2017‒2031

Table 5: North America Smoking Cessation and Nicotine De-Addiction Market Value, by Distribution Channel, US$ Mn,2017‒2031

Table 6: North America Smoking Cessation and Nicotine De-Addiction Market Value, by Country and Sub-Region, US$ Mn, 2017‒2031

Table 7: Europe Smoking Cessation and Nicotine De-Addiction Market Value, by product Type, US$ Mn, 2017‒2031

Table 8: Europe Smoking Cessation and Nicotine De-Addiction Market Value, by Distribution Channel, US$ Mn,2017‒2031

Table 9: Europe Smoking Cessation and Nicotine De-Addiction Market Value, by Country and Sub-Region, US$ Mn, 2017‒2031

Table 10: Asia Pacific Smoking Cessation and Nicotine De-Addiction Market Value, by product Type, US$ Mn, 2017‒2031

Table 11: Asia Pacific Smoking Cessation and Nicotine De-Addiction Market Value, by Distribution Channel, US$ Mn,2017‒2031

Table 12: Asia Pacific Smoking Cessation and Nicotine De-Addiction Market Value, by Country and Sub-Region, US$ Mn, 2017‒2031

Table 15: MEA Smoking Cessation and Nicotine De-Addiction Market Value, by product Type, US$ Mn, 2017‒2031

Table 16: MEA Smoking Cessation and Nicotine De-Addiction Market Value, by Distribution Channel, US$ Mn,2017‒2031

Table 17: MEA Smoking Cessation and Nicotine De-Addiction Market Value, by Country and Sub-Region, US$ Mn, 2017‒2031

Table 18: South America Smoking Cessation and Nicotine De-Addiction Market Value, by product Type, US$ Mn, 2017‒2031

Table 19: South America Smoking Cessation and Nicotine De-Addiction Market Value, by Distribution Channel, US$ Mn,2017‒2031

Table 20: South America Smoking Cessation and Nicotine De-Addiction Market Value, by Country and Sub-Region, US$ Mn, 2017‒2031

---